$15.070
+0.701 (+4.65%)Zum Schluss
Umsatzquellen von MIR
Mirion Technologies, Inc. (MIR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Nuclear, accounting for 36.7% of total sales, equivalent to $81.80M. Other significant revenue streams include Cancer care and Labs and research. Understanding this composition is critical for investors evaluating how MIR navigates market cycles within the Industrial Machinery & Equipment industry.
Profitabilität und Margen von MIR
Evaluating the bottom line, Mirion Technologies, Inc. maintains a gross margin of 49.89%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.86%, while the net margin is 3.04%. These profitability ratios, combined with a Return on Equity (ROE) of 1.49%, provide a clear picture of how effectively MIR converts its operational activities into shareholder value.
MIR im Vergleich zur Peergroup
In the context of the broader market, MIR competes directly with industry leaders such as FLY and LUNR. With a market capitalization of $3.75B, it holds a significant position in the sector. When comparing efficiency, MIR's gross margin of 49.89% stands against FLY's 20.29% and LUNR's 10.16%. Such benchmarking helps identify whether Mirion Technologies, Inc. is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Mirion Technologies Inc
Mirion's recent financial performance shows mixed results, with total revenue increasing to $266.8 million in Q2 2026, but net income remains inconsistent, with a reported loss of $3.4 million in Q1 2026. Gross margin has improved to 49.89% in Q2 2026, indicating some operational efficiency.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.